Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

What is the role of serial high-sensitivity troponin measurements in chronic heart failure?

Gaggin HK, Januzzi JL Jr.

Clin Chem. 2012 Jul;58(7):1079-81. doi: 10.1373/clinchem.2012.183244. Epub 2012 Apr 3. No abstract available.

2.

Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.

Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R; Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca–Heart Failure (GISSI-HF) Investigators.

Circulation. 2012 Jan 17;125(2):280-8. doi: 10.1161/CIRCULATIONAHA.111.044149. Epub 2011 Dec 2.

3.

Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.

de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.

Am Heart J. 2012 May;163(5):821-8. doi: 10.1016/j.ahj.2012.03.004.

PMID:
22607860
4.

[Diagnostic and prognostic value of troponin T in patients with chronic and symptomatic heart failure].

Latini R, Masson S.

Recenti Prog Med. 2008 Oct;99(10):505-8. Italian.

PMID:
19040129
5.

Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP.

Clin Chem. 2010 Nov;56(11):1718-24. doi: 10.1373/clinchem.2009.141341. Epub 2010 Sep 15.

6.

Whose heart will get broken? Troponin testing and future heart failure.

van Kimmenade RR, Januzzi JL Jr.

Eur Heart J. 2009 Apr;30(7):755-6. doi: 10.1093/eurheartj/ehp092. Epub 2009 Mar 4. No abstract available.

7.

The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).

Gheorghiade M, Gattis Stough W, Adams KF Jr, Jaffe AS, Hasselblad V, O'Connor CM.

Am J Cardiol. 2005 Sep 19;96(6A):18G-25G.

PMID:
16181819
8.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

Felker GM, Hasselblad V, Hernandez AF, O'Connor CM.

Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9.

PMID:
19699866
9.

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators.

Circulation. 2007 Sep 11;116(11):1242-9. Epub 2007 Aug 13.

10.

Are multiple biomarker testing strategies ready for prime time in heart failure?

Lee DS, Tu JV.

Circ Heart Fail. 2009 Sep;2(5):387-8. doi: 10.1161/CIRCHEARTFAILURE.109.898429. No abstract available.

11.

Prognostic use of cardiac troponin T and troponin I in patients with heart failure.

Healey JS, Davies RF, Smith SJ, Davies RA, Ooi DS.

Can J Cardiol. 2003 Mar 31;19(4):383-6.

PMID:
12704483
12.

Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure.

Setsuta K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada A, Takano T, Kishida H, Hayakawa H.

Am J Cardiol. 1999 Sep 1;84(5):608-11, A9.

PMID:
10482168
13.

Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.

Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC Jr, Jaffe AS.

Circulation. 2007 Jul 17;116(3):249-57. Epub 2007 Jun 25.

14.

[Single cardiac troponin T measurement predicts risk for adverse outcome in decompensated heart failure].

Oliveira MD, Alvares J, Moreira MC.

Arq Bras Cardiol. 2010 Apr;94(4):527-34. Epub 2010 Mar 26. Portuguese.

15.

Sensitive cardiac troponin T assay.

Lippi G, Cervellin G, Plebani M.

N Engl J Med. 2010 Apr 1;362(13):1242; author reply 1243. doi: 10.1056/NEJMc1000952. No abstract available.

16.

Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure.

Ishii J, Cui W, Kitagawa F, Kuno T, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Nagamura Y, Kondo T, Oshima H, Nomura M, Ezaki K, Hishida H.

Clin Chem. 2003 Dec;49(12):2020-6.

17.

Cardiac troponin T for risk stratification in decompensated chronic heart failure.

Del Carlo CH, Pereira-Barretto AC, Cassaro-Strunz CM, Latorre Mdo R, Oliveira Junior MT, Ramires JA.

Arq Bras Cardiol. 2009 May;92(5):372-80, 389-97, 404-12. English, Multiple languages.

18.

Cardiac troponin I seems to be superior to cardiac troponin T in the early detection of cardiac injury associated with anthracycline treatment.

Horacek JM, Pudil R, Tichy M, Jebavy L, Strasova A, Ulrychova M, Zak P, Maly J.

Onkologie. 2008 Oct;31(10):559-60. doi: 10.1159/000151687. Epub 2008 Sep 23. No abstract available.

19.

High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure.

Perna ER, Macín SM, Cimbaro Canella JP, Alvarenga PM, Pantich RE, Ríos NG, Cialzeta JR, Farías EF, Badaracco JR, Brizuela M, Jantus E, Missov ED.

Med Sci Monit. 2004 Mar;10(3):CR90-5. Epub 2004 Mar 1.

PMID:
14976458
20.

Increased levels of cardiac troponin-T in outpatients with heart failure and preserved systolic function are related to adverse clinical findings and outcome.

Macin SM, Perna ER, Cimbaro Canella JP, Augier N, Riera Stival JL, Cialzeta J, Pitzus AE, Obregon R, Garcia E, Medina F, Badaracco RJ.

Coron Artery Dis. 2006 Dec;17(8):685-91.

PMID:
17119377
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk